Skip to content

Effect of Liposomal Bupivacaine Pecs? Block on Postoperative Pain after Immediate Breast Reconstruction following Laparoscopic Radical Mastectomy

Effect of Liposomal Bupivacaine Pecs? Block on Postoperative Pain after Immediate Breast Reconstruction following Laparoscopic Radical Mastectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110309
Enrollment
Unknown
Registered
2025-10-11
Start date
2025-10-11
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Liposomal Bupivacaine Group:Dilute 20 ml of 1.3% liposomal bupivacaine to 30 ml for Pecs? Block
Ropivacaine group:0.25% ropivacaine 30ml for Pecs? Block

Sponsors

Tianjin Cancer Hospital (Tianjin Medical University Cancer Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age: 20 to 65 years old; 2. American Society of Anesthesiologists (ASA) Grade I and II; 3. Patients who have been diagnosed with breast cancer and are scheduled to undergo endoscopic radical mastectomy and immediate breast reconstruction.

Exclusion criteria

Exclusion criteria: 1. Has a history of neurological diseases, mental disorders, heart and lung diseases, and liver and kidney function impairments; 2. Allergy to local anesthetics or liposome components; 3. Abnormal coagulation function; 4. Infection at the puncture site; 5. Long-term oral analgesics; 6. Patients with concurrent other cancers or distant metastases; 7. Postoperative pain assessment or follow-up after surgery.

Design outcomes

Primary

MeasureTime frame
Resting VAS score;Excercise VAS score;The incidence rate of chronic pain;

Secondary

MeasureTime frame
Total consumption of opioid drugs;The effective pressing times of the analgesia pump;Number of rescue analgesia times;Adverse reactions related to opioid drugs;The quality of the patient's recovery;

Countries

China

Contacts

Public ContactDeng Chengqi

Tianjin Cancer Hospital (Tianjin Medical University Cancer Hospital)

xiaodengzi_315@163.com+86 22 2334 0123

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026